Results 181 to 190 of about 588,754 (299)

SULF1 and EPB41L3: Potential Biomarkers of Acute Myocardial Infarction and the Vascular Inflammatory Milieu. [PDF]

J Inflamm Res
Zhu H, Xu X, Zhu X, Huang J, Cai L, Gao B, Yang C, Wang S, Chen Q, Fang X, Zheng J, Bao C, Chen T.   +12 more
europepmc   +1 more source

Population Pharmacokinetics of Ticagrelor during Veno‐Arterial ECMO in Acute Coronary Syndrome: Model‐Informed Dosing Simulations

Clinical Pharmacology &Therapeutics, EarlyView.
Although patients with acute coronary syndrome supported by veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) have a high risk of thrombosis and bleeding, antiplatelet pharmacology in this setting is not well defined. This prospective observational study investigated the population pharmacokinetics of ticagrelor and its active metabolite AR ...
Soyoung Kang, Kyoung Lok Min, Seungwon Yang, Jongsung Hahn, Dasohm Kim, Byung Hak Jin, Soon Uk Chae, Soo Kyung Bae, Jin Wi, Min Jung Chang   +9 more
wiley   +1 more source

Universal Early Discharge Protocol for Acute Myocardial Infarction: A Single-Center Prospective Validation. [PDF]

Vasc Health Risk Manag
Bauer D, Berka V, Neuberg M, Odvodyová D, Maliničová I, Lašmanská S, Smitalová S, Mašek P, Kočka V, Moťovská Z, Kozel M, Bartošková K, Toušek P.   +12 more
europepmc   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Self-gated late gadolinium enhancement at 7T to image rats with reperfused acute myocardial infarction [PDF]

, 2018
Chen, Wei, Chen, Yushu, Gao, Fabao, Song, Li, Wang, Chunhua, Wang, Lei, Xu, Ziqian, Zhang, Bing, Zheng, Jie   +8 more
core   +2 more sources

Real‐World Comparison of Vascular Access Closure Strategies in TAVI

Catheterization and Cardiovascular Interventions, EarlyView.
Saif Zako, Kathrin Klein, Karin Alde, Christian Jung, Verena Veulemanns, Maximilian Scherner, Artur Lichtenberg, Malte Kelm, Tobias Zeus, Amin Polzin   +9 more
wiley   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Hematological parameters as predictors of complex angiographic coronary lesions in patients with acute myocardial infarction. [PDF]

PLoS One
Ramos TMB, Monteiro Júnior JGM, Furtado VC, de Paula MLS, Bastos BF, Pires MJO, Montarroyos UR, Sobral Filho DC.   +7 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Proteomics-based biomarkers of plasma exosomes from patients with acute myocardial infarction. [PDF]

PLoS One
Wang Y, Li H, Mou W, Zhu J.
europepmc   +1 more source